-
-
Toggle navigation
The 5th most cited journal in Immunology
Scope
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology.
Read more
>
Scope & Mission
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Frontiers in Immunology is official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Further, the availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology portrays how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treat immune disorders, both in animal and cellular models and in humans.
All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals.
Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.
Frontiers in Immunology is a member of the Committee on Publication Ethics.
Short Name: Front. Immunol.
Abbreviation: fimmu
Electronic ISSN: 1664-3224
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, EBSCO, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
Submission
Frontiers in Immunology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Immunology welcome submission of the following article types: Case Report, Classification, Clinical Study Protocol, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Systematic Review, Book Review, Data Report, General Commentary, Protocols, Specialty Grand Challenge, Technology Report, Addendum, Erratum and Frontiers Commentary.
When submitting a manuscript to Frontiers in Immunology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Immunology.
Frontiers Editorial Office
EPFL - Innovation Square, Building I
CH – 1015 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
-
- All sections
- Alloimmunity and Transplantation
- Antigen Presenting Cell Biology
- B Cell Biology
- Cancer Immunity and Immunotherapy
- Comparative Immunology
- Cytokines and Soluble Mediators in Immunity
- HIV and AIDS
- Immunological Memory
- Immunological Tolerance and Regulation
- Inflammation
- Microbial Immunology
- Molecular Innate Immunity
- Mucosal Immunity
- Multiple Sclerosis and Neuroimmunology
- NK and Innate Lymphoid Cell Biology
- Nutritional Immunology
- Primary Immunodeficiencies
- T Cell Biology
- Vaccines and Molecular Therapeutics
- Editor(s) found
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This journal has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
EPFL - Innovation Square, Building I
CH – 1015 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01